Evidence map›Paper›PMID 40890728›Full record

ArticleBMC pediatrics2025

Neonatal neurodevelopmental follow-up in the UK: a survey of current practice and future recommendations.

Claire Marcroft, Hilary Cruickshank, Samantha Johnson, Catherine Exley, Niina Kolehmainen, Richard Thomson, Anna Basu

Abstract read
In one paragraph

Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claire MarcroftNewcastle Neonatal Service, Newcastle upon Tyne NHS Foundation Trust, Royal Victoria Infirmary, Newcastle Upon Tyne, England, UK. c.marcroft@nhs.net.
Hilary CruickshankSimpson Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Samantha JohnsonDepartment of Population Health Sciences, University of Leicester, Leicester, UK.
Catherine ExleyPopulation Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
Niina KolehmainenPopulation Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
Richard ThomsonPopulation Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
Anna BasuPopulation Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.

Funding

National Institute for Health and Care Research ICA-CDRF-2018-04-ST2-020
6 · The paper itself

Abstract

backgroundTo assess the clinical service provision of neonatal follow-up services in the UK in line with UK National Institute for Health and Care Excellence (NICE) guideline NG72, 'Developmental follow-up of children and young people born preterm'.

methodsDesign: Online survey.

settingNeonatal units in England, Scotland and Wales (n = 187) in July- September 2022.

participantsLead neonatal clinicians for neurodevelopmental follow-up.

resultsResponses were received from 154 neonatal units, representing 82% of the total. This included 52 out of 58 (89%) Neonatal Intensive Care Units, 68 out of 86 (79%) Local Neonatal Units, and 34 out of 43 (79%) Special Care Baby Units. In total, 136 units (88%) provided neurodevelopmental follow-up for infants born before 30 weeks' gestation, and 75 units (51%) did so for those born before 32 weeks' gestation. Out of 145 responses, 134 units (92%) offered follow-up to infants with brain injury requiring cooling therapy. A 2-year neurodevelopmental face-to-face appointment was available for infants born before 30 weeks' gestation in 129 units (83%), while only ten units (6%) provided a 4-year assessment for those born before 28 weeks' gestation. Additionally, just 13 units (9.6%) directed families to peer support services.

conclusionsThe structure and content of neonatal neurodevelopmental follow-up vary widely. Notably, there is a lack of 4-year assessments for infants born preterm, representing a missed opportunity to support school readiness. KEY MESSAGES: What is already known on this topic? Neonatal neurodevelopmental follow-up is a vital aspect of care for early detection of difficulties, timely access to intervention, promotion of long-term health and wellbeing and data collection to contribute to parental counselling. Delivery of neonatal follow-up in line with UK clinical guidelines has not been evaluated. What this study hopes to add. There is wide variation in the inclusion criteria, content, and duration of neonatal neurodevelopmental follow-up in the UK. Only 6.8% of services reported offering infants born < 28 weeks' gestation a face-to-face appointment at four years of age. Recognition that the informational needs of parents may be conflated with the data requirements of clinicians, and this may contribute to suboptimal clinical service provision and limited reliable outcome data. How this study might affect research, practice, or policy. This study highlights the lack of neurodevelopmental surveillance and support for children born < 28 weeks' gestation at four years of age. These data provide evidence for Operational Delivery Networks (ODNs) to understand how neonatal neurodevelopmental follow-up is delivered within their area. This will help inform families about available services, facilitate joint work, and deliver more equitable neonatal follow-up in the UK. Clinicians could improve information sharing with families by signposting to trusted local, community, online, or third-sector support. Further research is necessary to comprehensively understand neonatal and paediatric developmental services from a parent/caregiver perspective and a systems and processes perspective. Clinical policy and guidelines should provide further clarity regarding which services are most appropriate and responsible for delivering this care.

Indexed as

AftercareNeurodevelopmental DisordersChild DevelopmentFollow-Up StudiesHealth Care SurveysHumansInfant, NewbornInfant, PrematureIntensive Care Units, NeonatalPractice Guidelines as TopicUnited KingdomFollow-upHigh-riskInfantNeonatalNeurodevelopmentPrematurePreterm

Identifiers

PMID40890728
PMCPMC12400706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.